Diflucortolone valerate loaded solid lipid nanoparticles as a semisolid topical delivery system

Pardeike, 2009, Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products, Int J Pharm, 366, 170, 10.1016/j.ijpharm.2008.10.003 Pawar, 2012, Solid lipid nanoparticles; the beneficial carrier for the delivery of lipid soluble drugs, IJPRD, 3, 200 Jenning, 2000, Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin, Eur J Pharm Biopharm, 49, 211, 10.1016/S0939-6411(99)00075-2 Muller, 2000, Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art, Eur J Pharm Biopharm, 50, 161, 10.1016/S0939-6411(00)00087-4 Lippacher, 2002, Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties, Eur J Pharm Biopharm, 53, 155, 10.1016/S0939-6411(01)00233-8 Lippacher, 2001, Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles, Int J Pharm, 214, 9, 10.1016/S0378-5173(00)00623-2 Ozcan, 2013, Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations, Int J Nanomed, 8, 461, 10.2147/IJN.S40519 Coutinho, 2011, The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights, Mol Cell Endocrinol, 335, 2, 10.1016/j.mce.2010.04.005 Refai H. Studies on the parameters affecting hydrocortisone release and permeation through excised human stratum corneum with emphasis on the influence of dilution [Ph.D. thesis]. University of Carolo-Wilhelmina; 2001. Palabiyik, 2006, Liquid chromatographic and spectrophotometric determination of diflucortolone valerate and chlorquinaldol in creams, J Food Drug Anal, 15, 145 2012 Havlickova, 2008, The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses, Mycoses, 51, 16, 10.1111/j.1439-0507.2008.01615.x Rawlins, 1977 Ekambaram, 2012, Solid lipid nanoparticles: a review, Sci Revs Chem Commun, 2, 80 Jensen, 2010, Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles, Int J Pharm, 390, 53, 10.1016/j.ijpharm.2009.10.022 Priyanka, 2012, Preparation and evaluation of montelukast sodium loaded solid lipid nanoparticles, J Young Pharm, 4, 129, 10.4103/0975-1483.100016 Niculae, 2013, Optimization of lipid nanoparticles composition for sunscreen encapsulation, UPB Sci Bull, 75, 79 Miner, 1993 Ammar, 2011, Preparation and evaluation of hydrogels as a vehicle for topical delivery of lornoxicam, IJDFR, 2, 254 Escobar-Chávez, 2006, Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations, J Pharm Pharmaceut Sci, 9, 339 Illing, 2004, Investigation on the flow behavior of dispersion of solid triglyceride nanoparticles, Int J Pharm, 284, 123, 10.1016/j.ijpharm.2004.07.017 Boudreaux, 2002, Lipids Oh, 2002, Characterization and thermal stability of polymorphic forms of synthesized tristearin, Food Chem Toxicol, 67, 2911 Sinha, 2010, Solid lipid nanoparticles (SLN’s) – trends and implications in drug targeting, Int J Adv in Pharm Sci, 1, 212